Patrick J McEnany insider trades

Open-market stock purchases and sales by Patrick J McEnany, Director at Catalyst Pharmaceuticals, Inc, from SEC Form 4 filings since Jun 15, 2010.

Recent trades

DateStockTradeValue
Jul 15, 2026CPRX Catalyst Pharmaceuticals, IncSold (not open market)$131M
Jul 15, 2026CPRX Catalyst Pharmaceuticals, IncSold (not open market)—
Jul 15, 2026CPRX Catalyst Pharmaceuticals, IncSold (not open market)—
Jul 15, 2026CPRX Catalyst Pharmaceuticals, IncSold (not open market)—
Jul 15, 2026CPRX Catalyst Pharmaceuticals, IncSold (not open market)—
Jul 15, 2026CPRX Catalyst Pharmaceuticals, IncSold (not open market)—
Jul 15, 2026CPRX Catalyst Pharmaceuticals, IncSold (not open market)—
Jul 15, 2026CPRX Catalyst Pharmaceuticals, IncSold (not open market)—
Jul 15, 2026CPRX Catalyst Pharmaceuticals, IncSold (not open market)—
Jul 15, 2026CPRX Catalyst Pharmaceuticals, IncSold (not open market)—
Jul 15, 2026CPRX Catalyst Pharmaceuticals, IncSold (not open market)—
Dec 29, 2025CPRX Catalyst Pharmaceuticals, IncSold (not open market)—
Dec 29, 2025CPRX Catalyst Pharmaceuticals, IncBought (not open market)—
Dec 8, 2025CPRX Catalyst Pharmaceuticals, IncBought (not open market)—
Dec 1, 2025CPRX Catalyst Pharmaceuticals, IncSold (not open market)—
Nov 21, 2025CPRX Catalyst Pharmaceuticals, IncBought (not open market)—
Nov 20, 2025CPRX Catalyst Pharmaceuticals, IncBought (not open market)—
Nov 20, 2025CPRX Catalyst Pharmaceuticals, IncBought (not open market)—

Companies traded

  • CPRX Catalyst Pharmaceuticals, Inc: 31 buys, 21 sales, last Jul 15, 2026
  • KOOL Cesca Therapeutics Inc: other filings, last Jul 1, 2014

Get free alerts when Patrick J McEnany files a new trade →